DNA script

DNA Script, founded in Paris in 2014, is an industry leader in enzymatic DNA de novo synthesis technology. The latest round of financing will enable DNA Script to enhance its unique enzymatic technology and nucleotide chemistry platform, making DNA synthesis faster and more cost-effective than current market standards.At the core of DNA Script's R&D efforts are innovations in enzyme engineering, surface and nucleotide chemistry, and instrumentation. The integration of these cutting-edge technologies has led to SYNTAXTM, the world’s first benchtop DNA printer utilizing enzymatic technology. With continuous advancements and innovation, DNA Script believes that its enzymatic DNA synthesis technology has the potential to become a driving force for genomics research and personalized medicine.